Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis
- PMID: 28992164
- PMCID: PMC5850118
- DOI: 10.1093/rheumatology/kex193
Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis
Abstract
Patients with SSc have the highest mortality among the rheumatic diseases. In addition, SSc is associated with disfigurement, hand contractures, fatigue, poor sleep, severe RP with numbness and tingling of the fingers can lead to decrements in quality of life. This Points to Consider article provides practical considerations for design of trials for functional disability and other health-related quality-of-life issues.
Keywords: clinical trials; function; quality of life; scleroderma.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
References
-
- Khanna D, Tsevat J.. Health-related quality of life–an introduction. Am J Managed Care 2007;13 (Suppl 9):S218–23. - PubMed
-
- Cella DF, Bonomi AE.. Measuring quality of life: 1995 update. Oncology 1995;9:47–60. - PubMed
-
- Khanna D, Furst DE, Clements PJ. et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832–40. - PubMed
-
- Thombs BD, Hudson M, Taillefer SS, Baron M; Canadian Scleroderma Research Group. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 2008;59:504–9. PubMed PMID: 18383422. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
